Presumably, prostate tumor cells that have lost the ability to express functional MXD1 or RGS4 would lose the capacity to enforce these observed Poly E-mediated antiproliferative effects on PC-3 cells, and perhaps other PCa cells as well. The gene discussed is MXD1; the disease is prostate neoplasm.